Thanks to @stemcellnetwork.ca for a fantastic #TMM2025 conference.

Highlights:
🎉 Celebrating our partnership with SCN @breakthrought1dca.bsky.social
📝 Learning about regenerative medicine updates in #T1D
💭 Thought-provoking sessions on science funding, policy, and commercialization

Unfortunate to see today’s news from Vertex about their VX-264 therapy for #T1D but this is why we always have ‘multiple shots on goal’!

Considering that the same cells are being used as in VX-880 (so far great data) it’s reasonable to assume that the device encapsulation was the problem here.

Really fascinating debate at #ATTD2025 about whether or not we should use placebos in trial design for preventative therapies of #T1D now that Tzield (teplizumab) has shown efficacy and is approved in a few countries. Heavy hitters Colin Dayan and Laura Jacobsen presented excellent points!

Thrilled to (virtually) watch a fantastic talk at #ATTD2025 from Dr. Cristina Nostro about co-culturing pluripotent stem cells with macrophages which not only provides protection but also increases endocrine output!

Breakthrough T1D Canada has worked very closely with CIHR INMD over the past 6 years to double funding to #T1D research - $60M jointly spent since 2019!!

Now they are looking for a new Scientific Director - check it out here if you’re interested! www.cihr-irsc.gc.ca/e/54128.html

ATTN Canadian and International trainees!

The J. Andrew McKee Fellowship is open. Notice of intent is due JAN 30, 2025!!

Supported by Breakthrough T1D Canada and Stem Cell Network of Canada, this PDF brings aspiring scientists to the BT1D Centre of Excellence at UBC!
t.co/dDWHluBbrX